New Medicine - A Comprehensive Information and Consulting Service  
HOME PRODUCTS & SERVICES ORDER/INQUIRY PRESS RELEASES EMPLOYMENT CONTACT US

FUTURE ONCOLOGY
Volume 5 #8/9 June 15, 2000
State-of-the-Art in the Management of Cancer

LUNG CANCER-PART V

Non-small-cell Lung Cancer-Current Management Strategies and Treatment Monitoring

 

Epidemiology by Stage

Incidence by Stage

First-year and Five-year Survival by Stage

Treatment Approaches by Stage

 

Surgery

Curative Surgery

Video-assisted Thoracic Surgery (VATS)

 

Surgery in Lung Metastases

 

Radiotherapy (RT)

Brachytherapy

Proton Radiotherapy

 

Chemotherapy/Chemoradiotherapy

Approved Drugs in NSCLC

 

Types of First-line Chemotherapy in NSCLC

Single-agent chemotherapy

Combination chemotherapy

Dose-intensive chemotherapy

 

Second-line Chemotherapy in NSCLC

 

Biologic Agents

Other Agents

Amofistene

 

Adjuvant, Neoadjuvant  and Multimodality Therapy

Other Treatment Modalities

Laser Ablation

Photodynamic Therapy

Hyperthermia

Perfusion-induced systemic hyperthermia (PISH)

 

Cryotherapy

Radiofrequency bronchoscopic surgery with cryotherapy

 

Management of Cancer Metastasized to the Lung

 

Treatment Monitoring

 


HOME | PRODUCTS & SERVICES | ORDER/INQUIRY | PRESS RELEASES | EMPLOYMENT | CONTACT US

NEW MEDICINE, INC.
PHONE: 949-830-0448   FAX: 949-830-0887